Record-Breaking Price Performance
On 25 May 2026, Park Medi World Ltd’s share price touched an intraday high of Rs.273.4, surpassing its previous 52-week peak of Rs.266.95 by approximately 2.4%. This new all-time high represents a remarkable appreciation from the 52-week low of Rs.138.15, indicating a substantial gain of nearly 98% from the lowest point in the past year.
The stock outperformed its hospital sector peers by 4.57% on the day, closing with a robust 5.36% gain compared to the Sensex’s modest 1.11% rise. This performance is part of a recent upward trend, with the stock recording consecutive gains over the last two sessions, delivering a cumulative return of 6.1% during this period.
Strong Relative and Absolute Returns
Park Medi World Ltd’s price momentum extends beyond the immediate trading day. Over the past week, the stock has surged 13.64%, significantly outpacing the Sensex’s 1.25% advance. The one-month performance is even more striking, with a 17.77% increase against a slight decline of 0.53% in the benchmark index.
Over a three-month horizon, the stock has delivered an impressive 45.05% return, contrasting sharply with the Sensex’s 7.32% loss. Year-to-date, Park Medi World Ltd has soared by 86.46%, while the Sensex has declined by 10.52%. These figures underscore the stock’s resilience and strong relative strength within the hospital sector and the broader market.
Technical Indicators Signal Mildly Bullish Trend
Technical analysis supports the positive price action, with the overall trend classified as mildly bullish since 19 May 2026, when the stock crossed the Rs.247.3 level. Park Medi World Ltd is currently trading above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained upward momentum.
Among technical indicators, Bollinger Bands show a bullish pattern, while other metrics such as RSI and MACD currently indicate no strong signals, suggesting room for further price stability. Immediate support is anchored at the 52-week low of Rs.138.15, while resistance levels have been surpassed, with the previous 52-week high of Rs.266.95 now serving as a new benchmark.
Valuation Metrics Reflect Premium Pricing
At the current price of Rs.273.35, Park Medi World Ltd trades at a price-to-earnings (P/E) ratio of 47 times trailing twelve months earnings, reflecting a premium valuation consistent with its growth profile and sector positioning. The price-to-book value stands at 5.53 times, while enterprise value multiples include EV/EBITDA at 25.01 times and EV/EBIT at 29.10 times.
These valuation multiples indicate investor willingness to pay a premium for the company’s earnings and cash flow generation capabilities, aligned with its strong operational metrics and market standing. Dividend metrics remain unavailable, with no recent dividend payouts reported.
Quality Assessment Highlights Financial Strength
Park Medi World Ltd’s quality assessment reveals a solid financial foundation. The company maintains a good management risk profile and a strong capital structure, with low leverage evidenced by an average debt to EBITDA ratio of 1.33 and zero net debt to equity. Institutional holdings are moderate at 10.11%, and there is no promoter share pledging.
Return on capital employed (ROCE) is robust at 21.20%, underscoring efficient utilisation of capital. However, growth metrics over five years show no increase in sales or EBIT, indicating a stable but non-expansive operational footprint. The average EBIT to interest coverage ratio of 5.11 times is adequate, supporting financial flexibility.
Recent Financial Trends Show Mixed Signals
Quarterly financial data for March 2026 presents a nuanced picture. Profit after tax (PAT) rose by 28.7% to ₹8.61 crores compared to the previous four-quarter average, signalling improved profitability. Conversely, profit before tax excluding other income declined sharply by 80.5% to ₹1.34 crores, while net sales fell by 11.9% to ₹27.43 crores in the same period.
Non-operating income accounted for a significant 86.06% of profit before tax, highlighting the impact of ancillary income sources on overall profitability. The short-term financial trend is currently flat, reflecting a period of consolidation amid these mixed results.
Delivery Volumes Indicate Increased Trading Activity
Recent delivery volume trends show a 22.43% increase in daily delivery on 25 May 2026 compared to the five-day average, signalling heightened investor participation. Over the trailing one-month period, delivery volumes averaged 4.5 lakh shares, slightly lower than the previous month’s 4.65 lakh shares, but with a rising proportion of total volume at 46.38%.
Market Capitalisation and Sector Positioning
Park Medi World Ltd is classified as a small-cap company within the hospital sector. Its market cap grade reflects this status, positioning it among emerging players in the healthcare services industry. The company’s stock performance relative to the Sensex and sector benchmarks highlights its ability to generate superior returns despite its smaller size.
Summary of Key Metrics as of 25 May 2026
Price: Rs.273.35 (All-time high)
P/E Ratio (TTM): 47x
Price to Book Value: 5.53x
EV/EBITDA: 25.01x
ROCE: 21.20%
Institutional Holdings: 10.11%
Consecutive Gains: 2 days with 6.1% cumulative return
Year-to-date Return: 86.46%
Conclusion
Park Medi World Ltd’s ascent to an all-time high of Rs.273.4 on 25 May 2026 marks a significant achievement in its market trajectory. The stock’s strong relative performance, supported by positive technical indicators and a solid quality assessment, reflects the company’s resilience and financial strength within the hospital sector. While recent quarterly results present a mixed picture, the overall trend remains positive, with the stock outperforming key benchmarks and maintaining premium valuation multiples. This milestone underscores Park Medi World Ltd’s established position and the market’s recognition of its enduring value.
